Opiant Pharmaceuticals Inc (OPNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 33,443 | 35,450 | 48,251 | 31,103 | 30,502 |
| Marketable Securities | 15,072 | 12,598 | N/A | N/A | N/A |
| Receivables | 9,725 | 5,609 | 8,911 | 8,613 | 6,286 |
| TOTAL | $60,518 | $56,104 | $59,099 | $40,578 | $38,682 |
| Non-Current Assets | |||||
| PPE Net | 109 | 140 | 171 | 202 | 233 |
| Investments And Advances | 0 | 2,501 | 0 | 0 | 0 |
| Intangibles | 12 | 13 | 13 | 13 | 14 |
| Other Non-Current Assets | 1,119 | 146 | 1,330 | 1,448 | 508 |
| TOTAL | $1,240 | $2,800 | $1,514 | $1,664 | $755 |
| Total Assets | $61,758 | $58,903 | $60,613 | $42,242 | $39,437 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,554 | 4,660 | 4,875 | 4,505 | 2,824 |
| Accrued Expenses | 891 | 481 | 909 | 1,435 | 988 |
| TOTAL | $5,784 | $6,149 | $6,420 | $6,701 | $5,106 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 859 | 355 | 360 | 818 |
| Other Non-Current Liabilities | 19,618 | 18,769 | 18,701 | 0 | 35 |
| TOTAL | $19,618 | $18,769 | $18,701 | $N/A | $35 |
| Total Liabilities | $25,402 | $24,918 | $25,121 | $6,701 | $5,141 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,400 | 4,331 | 4,292 | 4,258 | 4,258 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -65,850 | -67,533 | -64,689 | -64,004 | -64,729 |
| Other shareholders' equity | -19 | -14 | -27 | -115 | -311 |
| TOTAL | $36,356 | $33,986 | $35,492 | $35,541 | $34,296 |
| Total Liabilities And Equity | $61,758 | $58,903 | $60,613 | $42,242 | $39,437 |